Comparative analysis of pediatric Respiratory Syncytial Virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada
暂无分享,去创建一个
A. Solimano | J. Srigley | P. Lavoie | J. Bone | D. Goldfarb | D. Skowronski | F. Reicherz | B. Abu-Raya | R. Xu | M. Vineta Paramo | M. Viñeta Paramo
[1] S. V. van Haren,et al. Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection , 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[2] S. Madhi,et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis , 2022, The Lancet.
[3] F. García-Muñoz Rodrigo,et al. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis. , 2022, Paediatric and perinatal epidemiology.
[4] M. Jit,et al. Determinants of RSV epidemiology following suppression through pandemic contact restrictions , 2021, Epidemics.
[5] A. Elliot,et al. The Epidemiology of Respiratory Syncytial Virus in Children Under Five Years-Old During the COVID-19 Pandemic Measured by Laboratory, Clinical and Syndromic Surveillance in England: A Retrospective Observational Study Including the 2020/21 Winter Season , 2022, SSRN Electronic Journal.
[6] E. Shapiro,et al. Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US , 2021, JAMA network open.
[7] S. Mukhi,et al. Seasonality of Respiratory Viruses at Northern Latitudes , 2021, JAMA network open.
[8] S. Tsuzuki,et al. Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan , 2021, Emerging infectious diseases.
[9] C. Delacourt,et al. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France , 2021, European Journal of Clinical Microbiology & Infectious Diseases.
[10] Wei Hao Lee,et al. Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia , 2021, Archives of Disease in Childhood.
[11] J. Langley,et al. Potential resurgence of respiratory syncytial virus in Canada , 2021, Canadian Medical Association Journal.
[12] S. de Lusignan,et al. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[13] J. Avner,et al. Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic , 2021, Pediatrics.
[14] M. van Boven,et al. Population-based serology reveals risk factors for RSV infection in children younger than 5 years , 2021, Scientific Reports.
[15] Sang Woo Park,et al. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections , 2020, Proceedings of the National Academy of Sciences.
[16] C. Sikazwe,et al. The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] P. Klenerman,et al. Humoral and cellular immunity to RSV in infants, children and adults. , 2018, Vaccine.
[18] K. Ishii,et al. Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection , 2017, EBioMedicine.
[19] S. Turvey,et al. Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab. , 2016, JAMA pediatrics.
[20] Eneida A. Mendonça,et al. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis , 2014, Pediatrics.